#metastatic-breast-cancer

[ follow ]
PortlandTribune.com
2 months ago
Medicine

Roche obtains CE Mark for first companion diagnostic to identify patients with HER2-low metastatic breast cancer eligible for ENHERTU

Approximately half of metastatic breast cancer patients express low HER2 levels, making them eligible for HER2-targeted treatment.
The VENTANA HER2 (4B5) test is approved to identify HER2-low status in metastatic breast cancer patients for targeted treatment. [ more ]
News Center
2 weeks ago
OMG science

Combination Therapy Shows Promise in Subset of Breast Cancers - News Center

Combining trastuzumab and pertuzumab for metastatic breast cancer in the cerebrospinal fluid is showing promising results. [ more ]
[ Load more ]